Publication Information

{'id': 'https://openalex.org/W1973926130', 'doi': 'https://doi.org/10.1517/13543776.13.6.751', 'title': 'The silatecans, a novel class of lipophilic camptothecins', 'display_name': 'The silatecans, a novel class of lipophilic camptothecins', 'publication_year': 2003, 'publication_date': '2003-06-01', 'ids': {'openalex': 'https://openalex.org/W1973926130', 'doi': 'https://doi.org/10.1517/13543776.13.6.751', 'mag': '1973926130'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543776.13.6.751', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S3784663', 'display_name': 'Expert Opinion on Therapeutic Patents', 'issn_l': '1354-3776', 'issn': ['1354-3776', '1744-7674'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5063365559', 'display_name': 'Richard Versace', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Richard W Versace', 'raw_affiliation_strings': ['Oncology Department, Novartis Institute for Biomedical Research, Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936, USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'Oncology Department, Novartis Institute for Biomedical Research, Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936, USA. [email protected]', 'institution_ids': ['https://openalex.org/I1283582996']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5063365559'], 'corresponding_institution_ids': ['https://openalex.org/I1283582996'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.227, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 13, 'citation_normalized_percentile': {'value': 0.561462, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 82, 'max': 83}, 'biblio': {'volume': '13', 'issue': '6', 'first_page': '751', 'last_page': '760'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12356', 'display_name': 'Bioactive Compounds and Antitumor Agents', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12172', 'display_name': 'Neutropenia and Cancer Infections', 'score': 0.9918, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/camptothecin', 'display_name': 'Camptothecin', 'score': 0.98017025}, {'id': 'https://openalex.org/keywords/topotecan', 'display_name': 'Topotecan', 'score': 0.7946613}, {'id': 'https://openalex.org/keywords/sn-38', 'display_name': 'SN-38', 'score': 0.42904106}], 'concepts': [{'id': 'https://openalex.org/C2779682216', 'wikidata': 'https://www.wikidata.org/wiki/Q419964', 'display_name': 'Camptothecin', 'level': 2, 'score': 0.98017025}, {'id': 'https://openalex.org/C2781209748', 'wikidata': 'https://www.wikidata.org/wiki/Q419953', 'display_name': 'Topotecan', 'level': 3, 'score': 0.7946613}, {'id': 'https://openalex.org/C2780259306', 'wikidata': 'https://www.wikidata.org/wiki/Q412197', 'display_name': 'Irinotecan', 'level': 4, 'score': 0.6643532}, {'id': 'https://openalex.org/C147897179', 'wikidata': 'https://www.wikidata.org/wiki/Q407828', 'display_name': 'Topoisomerase', 'level': 3, 'score': 0.64225173}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.57590806}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5231391}, {'id': 'https://openalex.org/C108215921', 'wikidata': 'https://www.wikidata.org/wiki/Q603741', 'display_name': 'Prodrug', 'level': 2, 'score': 0.44643673}, {'id': 'https://openalex.org/C2780508388', 'wikidata': 'https://www.wikidata.org/wiki/Q1750127', 'display_name': 'SN-38', 'level': 5, 'score': 0.42904106}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.33181503}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.2263785}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.2052427}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.1799404}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.139839}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.11601284}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543776.13.6.751', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S3784663', 'display_name': 'Expert Opinion on Therapeutic Patents', 'issn_l': '1354-3776', 'issn': ['1354-3776', '1744-7674'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.44, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 41, 'referenced_works': ['https://openalex.org/W1536538430', 'https://openalex.org/W1549846058', 'https://openalex.org/W1594148627', 'https://openalex.org/W1714506384', 'https://openalex.org/W1871475547', 'https://openalex.org/W1975616471', 'https://openalex.org/W1986010069', 'https://openalex.org/W2010113256', 'https://openalex.org/W2017231443', 'https://openalex.org/W2018185888', 'https://openalex.org/W2023555639', 'https://openalex.org/W2025007043', 'https://openalex.org/W2028088900', 'https://openalex.org/W2033605212', 'https://openalex.org/W2043703023', 'https://openalex.org/W2045116568', 'https://openalex.org/W2056249358', 'https://openalex.org/W2066266276', 'https://openalex.org/W2072106056', 'https://openalex.org/W2072533818', 'https://openalex.org/W2076044666', 'https://openalex.org/W2080742761', 'https://openalex.org/W2082497491', 'https://openalex.org/W2083833335', 'https://openalex.org/W2084429138', 'https://openalex.org/W2085054765', 'https://openalex.org/W2086179083', 'https://openalex.org/W2089217892', 'https://openalex.org/W2097197231', 'https://openalex.org/W2100113089', 'https://openalex.org/W2105024154', 'https://openalex.org/W2108018389', 'https://openalex.org/W2120892494', 'https://openalex.org/W2133295671', 'https://openalex.org/W2137690891', 'https://openalex.org/W2144872648', 'https://openalex.org/W2264818022', 'https://openalex.org/W2400590621', 'https://openalex.org/W2415036661', 'https://openalex.org/W2429945373', 'https://openalex.org/W2952750132'], 'related_works': ['https://openalex.org/W4225948320', 'https://openalex.org/W2941541752', 'https://openalex.org/W2128774674', 'https://openalex.org/W2119998088', 'https://openalex.org/W2104743561', 'https://openalex.org/W2098393177', 'https://openalex.org/W2072106056', 'https://openalex.org/W2028066947', 'https://openalex.org/W2013600522', 'https://openalex.org/W1988529521'], 'abstract_inverted_index': {'Camptothecin,': [0], 'a': [1, 14, 64, 94], 'potent': [2], 'cytotoxic': [3, 15], 'agent': [4, 30], 'that': [5, 69, 133, 147], 'inhibits': [6], 'topoisomerase': [7], 'I,': [8], 'was': [9, 50], 'identified': [10], 'in': [11, 17, 60, 88], '1966': [12], 'as': [13], 'component': [16], 'extracts': [18], 'of': [19, 47, 56, 97, 109, 119, 131, 154, 192], 'the': [20, 40, 48, 57, 61, 71, 77, 89, 104, 107, 136, 158, 176], 'Chinese': [21], 'tree': [22], 'Camptotheca': [23], 'acuminata.': [24], 'Initial': [25], 'clinical': [26], 'trials': [27, 41], 'with': [28], 'this': [29, 125], 'showed': [31], 'promising': [32], 'antitumour': [33], 'activity': [34, 98], 'but': [35], 'due': [36], 'to': [37, 53, 76, 183], 'unacceptable': [38], 'toxicity': [39, 49], 'were': [42, 67], 'halted.': [43], 'The': [44, 152], 'underlying': [45], 'cause': [46], 'soon': [51], 'determined': [52], 'be': [54], 'instability': [55], 'δ-lactone': [58], 'present': [59], 'structure.': [62], 'As': [63], 'result,': [65], 'analogues': [66, 132, 146], 'prepared': [68], 'overcame': [70], 'lactone': [72], 'instability,': [73], 'leading': [74], 'eventually': [75], 'chemotherapeutic': [78], 'drugs': [79, 85, 187], 'irinotecan': [80], 'and': [81, 93, 122, 168, 180, 197], 'topotecan.': [82], 'Although': [83], 'these': [84, 110], 'proved': [86], 'successful': [87], 'clinic,': [90], 'side': [91], 'effects': [92], 'narrow': [95], 'spectrum': [96], 'have': [99], 'limited': [100], 'their': [101], 'utility.': [102], 'In': [103], 'decade': [105], 'since': [106], 'development': [108], 'agents,': [111], 'continued': [112], 'research': [113], 'has': [114, 126], 'greatly': [115], 'improved': [116, 169], 'our': [117], 'understanding': [118], 'camptothecin': [120, 145, 159], 'stability': [121], 'pharmacology.': [123], 'From': [124], 'emerged': [127], 'several': [128], 'new': [129, 185], 'series': [130], 'will': [134, 173], 'produce': [135], 'next': [137], 'generation': [138, 144], 'camptothecin.': [139], 'Silatecans': [140], 'are': [141], 'novel': [142], 'third': [143], 'contain': [148], 'lipophilic': [149, 155], 'silane': [150], 'groups.': [151], 'incorporation': [153], 'substituents': [156], 'into': [157], 'structure': [160], 'provides': [161], 'enhanced': [162], 'blood': [163], 'stability,': [164], 'increased': [165], 'cell': [166], 'penetration': [167], 'pharmacokinetics.': [170], 'This': [171], 'review': [172], 'first': [174], 'examine': [175], 'various': [177], 'mechanisms': [178], 'involved': [179], 'approaches': [181], 'taken': [182], 'develop': [184], 'camptothecin-based': [186], 'followed': [188], 'by': [189], 'an': [190], 'analysis': [191], 'silatecan': [193], 'patents,': [194], 'example': [195], 'compounds': [196], 'biological': [198], 'data.': [199]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1973926130', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 3}], 'updated_date': '2024-12-07T21:07:49.813409', 'created_date': '2016-06-24'}